From searching a seemingly endless molecule database to generating molecules to understanding proteins, DNA and RNA, NVIDIA solutions are helping pharmaceutical and biopharmaceutical companies to discover and develop drugs faster and at a lower cost.
Don't miss these three upcoming Restaurant sessions at GTC.
NVIDIA Clara™ drug discovery is a GPU-accelerated computational drug discovery platform that combines AI, data analytics, simulation, and visualization to support cross-disciplinary workflows in drug design and development. Clara for drug discovery helps scientists and researchers get drugs to market faster and enables new possibilities for research into disease mechanisms.
Featured
See how NVIDIA Clara for drug discovery's MegaMolBart, a transformer-based NLP model developed with AstraZeneca and trained on millions of molecules, can quickly identify novel molecules for further investigation, increasing the probability of successful downstream experiments.
Featured
Featured
Featured
Featured
Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services.
Stay up to date with the latest healthcare news from NVIDIA.
NVIDIA technology and our innovators across multiple disciplines can help you power transformation, innovation, and the future of your organization.
The NVIDIA Deep Learning Institute (DLI) offers hands-on training in AI, accelerated computing, and accelerated data science.
NVIDIA provides access to hundreds of GPU-accelerated containers, models, and SDKs—all the tools necessary to successfully build apps with NVIDIA technology.